Amber Ophthalmics is a clinical stage biopharmaceutical company focused on ocular drug development. Since forming in 2020, the company has aspired to be a leader in the development of novel therapeutics through scientific innovation, addressing unmet ophthalmic medical needs.
Location: United States, California, San Diego
Member count: 1-10
Founded date: 2020